SoftBank Vision Fund 2 led the mobile engagement technology provider’s series C round, which closed at a $1.05bn valuation.

The Bristol Myers Squibb-backed oncology drug developer ultimately raised nearly $144m in its initial public offering.

The Engine was among the returning investors for the Rice spinout’s series B round, having previously backed a series A in 2019.

Genting has taken part in the hospitality and entertainment-focused payment app developer’s latest round, four months after its previous funding.

Byers is rumoured to be launching his own venture capital firm, Byers Capital, after stepping down as a general partner at GV.

Cisco Investments assisted the cybersecurity technology provider, which is also backed by NTT Docomo, in closing a $22.5m debt and equity round.

Equinor Ventures helped the photocatalyst reactor developer boost its overall funding to $35m in a round led by Horizons Ventures.

JGC Holdings bacame the latest investor in the modular nuclear reactor technology developer, which is already backed by a number of corporates.

Stanley Ventures participated in a series A round for Bartesian, which has created an intelligent cocktail maker and which is backed by Beam Suntory.

The drone-based crop analysis system developer secured $10.5m in a round led by Leaps by Bayer that also featured Cavallo Ventures and FMC Ventures.